Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells

The fludarabine and cyclophosphamide couplet has become the backbone of the chronic lymphocytic leukemia (CLL) standard of care. Although this is an effective treatment, it results in untoward toxicity. Bendamustine is a newly approved and better-tolerated alkylating agent. We hypothesized that simi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: El-Mabhouh, Amal A., Ayres, Mary L., Shpall, Elizabeth J., Baladandayuthapani, Veerabhadran, Keating, Michael J., Wierda, William G., Gandhi, Varsha
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2014
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4055925/
https://ncbi.nlm.nih.gov/pubmed/24747434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-541433
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller